The Role of Gastric Inhibitory Polypeptide in the Regulation of Pancreatic Endocrine Secretion

Total Page:16

File Type:pdf, Size:1020Kb

The Role of Gastric Inhibitory Polypeptide in the Regulation of Pancreatic Endocrine Secretion THE ROLE OF GASTRIC INHIBITORY POLYPEPTIDE IN THE REGULATION OF PANCREATIC ENDOCRINE SECRETION By CAMERON BRUCE VERCHERE B.Sc, The University of British Columbia, 1983 M.Sc, The University of British Columbia, 1987 A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSPHY in THE FACULTY OF GRADUATE STUDIES Department of Physiology We accept this thesis as conforming to the required standard THE UNIVERSITY OF BRITISH COLUMBIA August 1991 ©Cameron Bruce Verchere, 1991 In presenting this thesis in partial fulfilment of the requirements for an advanced degree at the University of British Columbia, I agree that the Library shall make it freely available for reference and study. I further agree that permission for extensive copying of this thesis for scholarly purposes may be granted by the head of my department or by his or her representatives. It is understood that copying or publication of this thesis for financial gain shall not be allowed without my written permission. Department The University of British Columbia Vancouver, Canada Date OCT. 7 > i^H I DE-6 (2/88) ii ABSTRACT Gastric inhibitory polypeptide (GIP) has often been referred to as glucose- dependent insulinotropic polypeptide because of its potent stimulatory effect on insulin secretion. A stimulatory action of GIP on the release of other islet hormones has also been suggested in certain studies. However, attempts to investigate the interaction of GIP with pancreatic islet cells at the molecular and cellular levels have been unsuccessful, presumably due to damage to the GIP receptor in the enzymatic isolation of pancreatic islets. The experiments presented here examined the hypothesis that GIP exerts a direct influence on the secretion of islet hormones via specific receptors. This was investigated primarily through the use of in vitro preparations of islets and /3-cells made more sensitive to the actions of GIP by tissue culture. Isolated rat islets, following two days of culture, responded to physiological concentrations of GIP (1 nM) with increased insulin, glucagon and somatostatin secretion. The stimulation of islet hormone secretion was dependent upon the concentrations of both GIP and glucose. The threshold glucose concentration for 1.0 nM GIP-stimulated insulin release from cultured islets was 8.9 mM and the maximum potentiation of GIP-stimulated insulin secretion was observed in the presence of 17.8 mM glucose. In 2.75 mM glucose, below the threshold for the insulinotropic action of GIP, the presence of arginine (10 mM) was sufficient to permit the stimulatory action of GIP on the 0-cell to occur, suggesting that non-glucose fuel stimuli can sensitize the /3-cell to the action of GIP. In contrast, glucagon release from isolated islets was stimulated by 1.0 nM GIP only in the presence of low glucose concentrations, as glucose levels greater than 2.75 mM attenuated the stimulatory effect of GIP on the a-cell. GIP-stimulated somatostatin secretion was not clearly glucose- iii dependent, although the maximum stimulation of somatostatin release by GIP occurred in 17.8 mM glucose. Acetylcholine (ACh) strongly suppressed somatostatin secretion induced by 17.8 mM glucose plus 10 nM GIP. Together, these results suggest that GIP is involved not only in the regulation of insulin and glucagon secretion, as was shown in previous studies, but also that GIP may regulate pancreatic somatostatin secretion. Further, the demonstration that GIP stimulated the release of these islet hormones in vitro indicates that the peptide acts directly on islet cells and that its effects are not dependent on indirect neural or vascular pathways. GIP-stimulated islet hormone secretion appears to be strongly influenced by the presence of glucose, other fuels and neural inputs. GIP also stimulated the release of insulin from a preparation of /3-cells sorted to > 98 % purity using a fluorescence-activated cell-sorter (FACS), confirming that GIP acts directly on the /3-cell to exert its insulinotropic effect. The sensitivity of FACS-purified B- cells to GIP was considerably less than intact islets, but could be enhanced by the addition of 10 nM glucagon or by culturing the cells with a non-/S-cell fraction obtained from the FACS that consisted of approximately 50 % a-cells. These results suggested that the mechanism of GIP-stimulated insulin secretion may partly involve intra-islet interactions, possibly with the islet a-cell. Other known insulin secretagogues increased secretion from FACS-purified j3-cells, including glucagon, glucagon-like peptide I (7-36-NH2), ACh and cholecystokinin-8 (CCK-8). GIP also stimulated insulin release from a mouse tumor 0-cell line (/3TC3). GIP-induced insulin secretion from /3TC3 cells was glucose-dependent and like FACS-purified /3-cells, was found to be approximately 100-fold less sensitive than isolated islets to the stimulatory effects of GIP. A mono-iodinated, biologically active form of 125I-GIP was purified by reverse- phase high performance liquid chromatography (HPLC) for use in radioreceptor binding iv studies with j8TC3 eells and cultured rat islets. Binding of the HPLC-purified radioligand to 0TC3 cells and cultured islets was displaced by GIP in a concentration-dependent manner starting at concentrations of GIP as low as 1 nM. 125I-GIP could not be displaced by numerous other peptides including those structurally related to GIP. The data strongly support the existence of a specific receptor for GIP on pancreatic j8-cells. A biotinylated form of GIP (B-GIP) was also produced and found to stimulate insulin release from the perfused rat pancreas and may therefore be a useful probe in future GIP receptor studies. Islets isolated from obese Zucker (fa/fa) rats were found to be more sensitive to the insulinotropic action of GIP than those of lean (Fa/?) rats. As had been observed in the perfused pancreas, the islets of obese but not lean rats responded to GIP (2.0 nM) in the presence of 4.4 mM glucose, below the normal threshold for the insulinotropic action of GIP. This could not be attributed to intra-islet interactions, since islet glucagon and somatostatin secretion from obese and lean rat islets were similar in 4.4 mM glucose plus GIP, and obese rat islets were more sensitive to the inhibitory effects of somatostatin. The results suggest the existence of a /3-cell defect in obese rats, possibly at the level of the GIP receptor or intracellular signal transduction. In 8.9 mM glucose, glucagon secretion from obese but not lean rat islets was suppressed compared to 4.4 mM glucose and enhanced by the addition of 2.0 nM GIP. The data indicate the presence of multiple alterations in hormone secretion from obese Zucker rat islets which remain apparent in culture, following removal of the islets from their in situ environment. These defects may contribute to the altered metabolic and obese state of fa/fa animals. GIP-stimulated insulin secretion from the perfused rat pancreas was potently suppressed by infusion of the pancreatic neuropeptide galanin. The inhibitory action of galanin appeared to be specific for GIP-stimulated insulin secretion, since the same V concentration of galanin (10 nM) had no effect on ACh- or CCK-8-stimulated insulin release and modestly suppressed the insulin response to arginine. The further demonstration that galanin suppressed GIP-induced insulin release from mixtures of FACS-purified B- and non-/3-cells suggests that galanin exerts its inhibitory influence on GIP-stimulated insulin release by a direct interaction at the level of the B-ce\\. Porcine galanin was without effect on somatostatin secretion from the perfused rat pancreas in the presence of GIP. In summary, these studies provided clear evidence that GIP directly interacts with the pancreatic islet to stimulate the release of insulin, glucagon and somatostatin. Moreover, it was shown that the stimulation of islet hormone secretion by GIP is subject to considerable modulation by glucose and other agents. The data further showed that alterations in islet sensitivity to GIP may contribute to the metabolic disturbances which exist in obese Zucker rats. Finally, a sensitive radioreceptor assay for GIP was developed and the presence of GIP receptors on rat pancreatic islets was demonstrated. vi TABLE OF CONTENTS Page ABSTRACT ii LIST OF TABLES xiv LIST OF FIGURES xv ACKNOWLEDGEMENTS xviii INTRODUCTION 1 METHODS 50 I. EXPERIMENTAL PREPARATIONS A. Animals 50 1. WistarRats 50 2. Zucker Rats 50 B. In Vitro Preparations 51 1. Isolated Islets 51 a) . Materials 51 b) . Islet Isolation 51 c) . Hormone Secretion from Isolated Islets 53 2. FACS-Purified Islet Cells 54 a) . Materials 54 b) . Islet Cell Preparation 55 c) . Purification of /3- and Non-/3 Islet Cells 56 d) . Culture of /?-Cells and Non-/?-Cells 56 e) . Immunocytochemical Characterization of Cell 58 Fractions vii f). Insulin Secretion Experiments 59 3. /3TC3 Tumor Cell Line 59 a) . Culture of /3TC3 Cells 61 b) . Insulin Secretion Experiments 61 4. Perfused Pancreas 62 a) . Apparatus 62 b) . Surgical Procedure 63 c) . Solutions 64 (i) . Perfusate 64 (ii) . Drugs and Peptides 64 d) . Perfusion Procedure 64 II. GIP RECEPTOR STUDIES A. GIP Receptor Probes 65 1. 125I-GIP 65 a) . Preparation of 125I-GIP 65 b) . HPLC Purification of 125I-GIP 68 c) . Specific Activity of 125I-GIP 69 d) . Analysis of HPLC-Purifiied 125I-GIP 70 e) . 127/125I-GIP 72 (i) . Preparation of 127/125I-GIP 72 (ii) . HPLC Purification of 127/125I-GIP 73 2. Biotinylated GIP (B-GIP) 73 a) . Preparation of B-GIP 73 b) . HPLC Purification of B-GIP 74 viii B. GIP Receptor Binding Studies 74 1. Assay Buffer 75 2. Peptides 75 3. Binding Assays 75 a) . )3TC3 Cells 76 b) . Isolated Islets 76 4. Calculations 77 III. PEPTIDE QUANTIFICATION A.
Recommended publications
  • Cells Using Gene Expression Profiling and Insulin Gene Methylation
    RESEARCH ARTICLE Comparison of enteroendocrine cells and pancreatic β-cells using gene expression profiling and insulin gene methylation ☯ ☯ Gyeong Ryul Ryu , Esder Lee , Jong Jin Kim, Sung-Dae MoonID, Seung-Hyun Ko, Yu- Bae Ahn, Ki-Ho SongID* Division of Endocrinology & Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea ☯ These authors contributed equally to this work. a1111111111 * [email protected] a1111111111 a1111111111 a1111111111 a1111111111 Abstract Various subtypes of enteroendocrine cells (EECs) are present in the gut epithelium. EECs and pancreatic β-cells share similar pathways of differentiation during embryonic develop- ment and after birth. In this study, similarities between EECs and β-cells were evaluated in OPEN ACCESS detail. To obtain specific subtypes of EECs, cell sorting by flow cytometry was conducted Citation: Ryu GR, Lee E, Kim JJ, Moon S-D, Ko S- from STC-1 cells (a heterogenous EEC line), and each single cell was cultured and pas- H, Ahn Y-B, et al. (2018) Comparison of saged. Five EEC subtypes were established according to hormone expression, measured enteroendocrine cells and pancreatic β-cells using by quantitative RT-PCR and immunostaining: L, K, I, G and S cells expressing glucagon-like gene expression profiling and insulin gene methylation. PLoS ONE 13(10): e0206401. https:// peptide-1, glucose-dependent insulinotropic polypeptide, cholecystokinin, gastrin and doi.org/10.1371/journal.pone.0206401 secretin, respectively. Each EEC subtype was found to express not only the corresponding Editor: Wataru Nishimura, International University gut hormone but also other gut hormones. Global microarray gene expression profiles of Health and Welfare School of Medicine, JAPAN revealed a higher similarity between each EEC subtype and MIN6 cells (a β-cell line) than Received: March 29, 2018 between C2C12 cells (a myoblast cell line) and MIN6 cells, and all EEC subtypes were highly similar to each other.
    [Show full text]
  • Enteric Nervous System (ENS): 1) Myenteric (Auerbach) Plexus & 2
    Enteric Nervous System (ENS): 1) Myenteric (Auerbach) plexus & 2) Submucosal (Meissner’s) plexus à both triggered by sensory neurons with chemo- and mechanoreceptors in the mucosal epithelium; effector motors neurons of the myenteric plexus control contraction/motility of the GI tract, and effector motor neurons of the submucosal plexus control secretion of GI mucosa & organs. Although ENS neurons can function independently, they are subject to regulation by ANS. Autonomic Nervous System (ANS): 1) parasympathetic (rest & digest) – can innervate the GI tract and form connections with ENS neurons that promote motility and secretion, enhancing/speeding up the process of digestion 2) sympathetic (fight or flight) – can innervate the GI tract and inhibit motility & secretion by inhibiting neurons of the ENS Sections and dimensions of the GI tract (alimentary canal): Esophagus à ~ 10 inches Stomach à ~ 12 inches and holds ~ 1-2 L (full) up to ~ 3-4 L (distended) Duodenum à first 10 inches of the small intestine Jejunum à next 3 feet of small intestine (when smooth muscle tone is lost upon death, extends to 8 feet) Ileum à final 6 feet of small intestine (when smooth muscle tone is lost upon death, extends to 12 feet) Large intestine à 5 feet General Histology of the GI Tract: 4 layers – Mucosa, Submucosa, Muscularis Externa, and Serosa Mucosa à epithelium, lamina propria (areolar connective tissue), & muscularis mucosae Submucosa à areolar connective tissue Muscularis externa à skeletal muscle (in select parts of the tract); smooth muscle (at least 2 layers – inner layer of circular muscle and outer layer of longitudinal muscle; stomach has a third layer of oblique muscle under the circular layer) Serosa à superficial layer made of areolar connective tissue and simple squamous epithelium (a.k.a.
    [Show full text]
  • S41467-019-14258-Z.Pdf
    ARTICLE https://doi.org/10.1038/s41467-019-14258-z OPEN Erythroid differentiation regulator-1 induced by microbiota in early life drives intestinal stem cell proliferation and regeneration Hirohito Abo1, Benoit Chassaing 1,2,3,4, Akihito Harusato 1, Miguel Quiros5, Jennifer C. Brazil5, Vu L. Ngo1, Emilie Viennois6, Didier Merlin6,7, Andrew T. Gewirtz1, Asma Nusrat5 & Timothy L. Denning1* 1234567890():,; Gut microbiota and their metabolites are instrumental in regulating intestinal homeostasis. However, early-life microbiota associated influences on intestinal development remain incompletely understood. Here we demonstrate that co-housing of germ-free (GF) mice with specific-pathogen free (SPF) mice at weaning (exGF) results in altered intestinal gene expression. Our results reveal that one highly differentially expressed gene, erythroid dif- ferentiation regulator-1 (Erdr1), is induced during development in SPF but not GF or exGF mice and localizes to Lgr5+ stem cells and transit amplifying (TA) cells. Erdr1 functions to induce Wnt signaling in epithelial cells, increase Lgr5+ stem cell expansion, and promote intestinal organoid growth. Additionally, Erdr1 accelerates scratch-wound closure in vitro, increases Lgr5+ intestinal stem cell regeneration following radiation-induced injury in vivo, and enhances recovery from dextran sodium sulfate (DSS)-induced colonic damage. Col- lectively, our findings indicate that early-life microbiota controls Erdr1-mediated intestinal epithelial proliferation and regeneration in response to mucosal damage. 1 Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, 100 Piedmont Ave, Atlanta, GA 30303, USA. 2 Neuroscience Institute and Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA. 3 INSERM, U1016, Paris, France. 4 Université de Paris, Paris, France.
    [Show full text]
  • Neural and Neuroendocrine Control of Digestion: Regulation of Gastrointestinal Hormone Secretion
    Neural and Neuroendocrine Control of Digestion: Regulation of Gastrointestinal Hormone Secretion (Chapter 15 in “Eckert Animal Physiology) (Chapter 4 in Hill, Wise & Anderson: “Animal Physiology”) (Chapter 10 in Hadley: “Endocrinology”) General Concepts Covered: — neural and neuroendocrine integration of a complex physiological process — co-ordination of endocrine and exocrine secretion — exocrine secretion affecting endocrine status — endocrine influences on neural, muscle and secretory functions — paracrine and autocrine effects — local influences — positive and negative “feed-back” actions — enzymatic cascades — integration of carbohydrate, fat and protein digestion and appetite control General Introduction — digestion requires co-ordination of movement of food particles, mechanical and chemical digestion of food — opening and closing of sphincter muscles to contain food particles in certain gut compartments for appropriate processing, also control passage through compartments — proper sequential enzymatic processing General Introduction (cont.) — peristaltic action to move food through gut — kneading movement to mix food particles with enzymes and to expose new surfaces for digestion, as well as for absorption From Eckert Secretin - first proposed hormone — 1902, WM Baylist and EH Starling (observations in dogs) — addition of food or acid in stomach is usually followed by pancreatic enzyme secretion into intestine — dennervate and tie off duodenum from stomach, then 1) add acid to stomach - no pancreatic enzyme secretion 2) add acid to
    [Show full text]
  • Pancreatic Amylase
    1. Functional Anatomy • The pancreas which lies parallel to and beneath the stomach is composed of: 1. The endocrine islets of Langerhans which secrete: Hormone Type of cell % of secretion Insulin Beta cells 60% crucial for normal regulation of glucose, Glucagon Alpha cells ~25% lipid & protein metabolism Somatostatin delta cells ~10% 1. Acinar gland tissues which produce pancreatic juice (the main source of digestive enzymes). • The pancreatic digestive enzymes are secreted by pancreatic acini. • Large volumes of sodium Bicarbonate solution are secreted by the small ductules and larger ducts leading from the acini. • Pancreatic juice is secreted in Response to the presence of Chyme in the upper portions of the small intestine. 2. Major Components of Pancreatic Secretion and Their Physiologic Roles & 5. Activation of Pancreatic Enzymes • The major functions of pancreatic secretion: 1. To neutralize the acids in the duodenal chyme to optimum range (pH= 7.0-8.0) for activity of pancreatic enzymes. 2. To prevent damage to duodenal mucosa by acid & pepsin. 3. To produce enzymes involved in the digestion of dietary carbohydrate, fat, and protein. Pancreatic Enzymes: The pancreas secrests enzymes that act on all major types of food stuffs. 1. Pancreatic Proteolytic Enzymes (Trypsin, Chymotrypsin, Carboxypolypeptidase, Elastase) • Trypsin & Chymotrypsin split whole and partially digested proteins into peptides of various sizes but do not cause release of individual amino acids. • Carboxypolypeptidase splits some peptides into individual amino acids, thus completing digestion of some proteins to amino acids. • When first synthesized in the pancreatic cells, digestive enzymes are in the inactive forms; these enzymes become activated only after they are secreted into the intestinal tract.
    [Show full text]
  • Secretin Stimulates the Secretion of Bile from the Liver. It Also Increases Watery Bicarbonate Solution from Pancreatic Duct Epithelium
    Name Secretin acetate Cat # PP-1670 Size 1 g, 10 g, 100, g and bulk custom packages CAS# 17034-35-4 Mol. Mass 3055.47 Formula C130H220N44O41 Sequence H-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Asp-Ser- Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2 Purity >95% Secretin is a peptide hormone produced in the S cells of the duodenum in the crypts of Lieberkühn. Its primary effect is to regulate the pH of the duodenal contents via the control of gastric acid secretion and buffering with bicarbonate. Secretin stimulates the secretion of bile from the liver. It also increases watery bicarbonate solution from pancreatic duct epithelium. Pancreatic acinar cells have secretin receptors in their plasma membrane. As secretin binds to these receptors, it stimulates adenylate cyclase activity and converts ATP to cyclic AMP.[12] Cyclic AMP acts as second messenger in intracellular signal transduction and leads to increase in release of watery carbonate.It is known to promote the normal growth and maintenance of the pancreas. Secretin increases water and bicarbonate secretion from duodenal Brunner's glands in order to buffer the incoming protons of the acidic chyme.[13] It also enhances the effects of cholecystokinin to induce the secretion of digestive enzymes and bile from pancreas and gallbladder, respectively. It counteracts blood glucose concentration spikes by triggering increased insulin release from pancreas, following oral glucose intake.<[14] It also reduces acid secretion from the stomach by inhibiting gastrin release from G cells.[citation needed] This helps neutralize the pH of the digestive products entering the duodenum from the stomach, as digestive enzymes from the pancreas (eg, pancreatic amylase and pancreatic lipase) function optimally at neutral pH.[citation needed] In addition, secretin simulates pepsin secretion which can help break down proteins in food digestion.
    [Show full text]
  • Cellular Localization of Gastric Inhibitory Polypeptide in the Duodenum and Jejunum
    Gut: first published as 10.1136/gut.14.4.284 on 1 April 1973. Downloaded from Gut, 1973, 14, 284-288 Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum JULIA M. POLAK, S. R. BLOOM', MARION KUZIO, J. C. BROWN, AND A. G. E. PEARSE From the Department ofHistochemistry, Royal Postgraduate Medical School, Hammersmith Hospital, London, and the Department ofPhysiology, University ofBritish Columbia, Vancouver, Canada SUMMARY Indirect immunofluorescence studies using an antiserum to purified porcine gastric inhibitory polypeptide indicate, in the gastrointestinal tract of dog and man, that this polypeptide is present in cells situated predominantly in the mid-zone of the glands in the duodenum and, to a lesser extent, in the jejunum. Absolute correlation of the gastric inhibitory polypeptide cell with one or other of the known endocrine-like cells identified by electron microscopy awaits confirmation by electron immunocytochemistry. It is here identified as an endocrine polypeptide cell of the APUD series and, provisionally, as the D, cell. While the hormonal status of a given polypeptide depends ultimately on physiological experiments the present results strengthen the view that gastric inhibitory polypeptide is indeed a hormone. In 1969 Brown, Pederson, Jorpes, and Mutt described We report here the results of immunofluorescence an enterogastrone, extractable from porcine intestine, studies on the localization of GIP in human and http://gut.bmj.com/ which strongly inhibited gastric acid secretion. The canine intestine. purification of an apparently similar enterogastrone was reported in the same year by Lucien, Itoh, Sun, Material and Methods Meyer, Carlton, and Schally. The first of these poly- peptides, named gastric inhibitory polypeptide Operative samples of duodenal and jejunal mucosa (GIP) by Brown, Mutt, and Pederson (1970), was from seven human subjects were studied.
    [Show full text]
  • Stomach, Duodenum, and Jejunum
    Gut, 1970, 11, 649-658 The endocrine polypeptide cells of the human Gut: first published as 10.1136/gut.11.8.649 on 1 August 1970. Downloaded from stomach, duodenum, and jejunum A. G. E. PEARSE, I. COULLING, B. WEAVERS, AND S. FRIESEN' From the Department of Histochemistry, Royal Postgraduate Medical School, London SUMMARY Thirty specimens of stomach, duodenum, and jejunum, removed at operation, were examined by optical microscopical, cytochemical, and electron microscopical techniques. The overall distribution of four types of endocrine polypeptide cell in the stomach, and three in the intestine, was determined. The seven cell types are described by names and letters belonging to a scheme for nomenclature agreed upon at the 1969 Wiesbaden conference o* gastrointestinal hormones. The gastrin-secreting G cell was the only cell for which firm identification with a known hormone was possible. Although there was wide variation in the distribution of the various cells, from one case to another, striking differences were never- theless observable, with respect to the G cell, between antra from carcinoma and from ulcer cases. http://gut.bmj.com/ This study was undertaken with a view to estab- tive shorthand terminology. Correlation with the lishing the overall topographical distribution of terminology used by Solcia, Vassallo, and Capella the various types of endocrine polypeptide cells (1969b) and by Vassallo, Solcia, and Capella in the human stomach and upper intestine. (1969) had to be equated, if possible, with the Adequate sampling was regarded as a pre- scheme used by Forssmann, Orci, Pictet, Renold, on September 28, 2021 by guest. Protected copyright.
    [Show full text]
  • 19780525 Gr Im.Pdf
    0 0 0 2 TABLE OF CONTENTS I INTRODUCTION II HISTORICAL BACKGROUND III ORIGIN AND NATURE OF GI HORMONES: NEUROENDOCRINE SECRETION AND RELEASE OF PEPTIDES IV ANATOMIC AND CELLULAR DISTRIBUTION OF GI HORMONES V CHEMICAL AND BIOLOGICAL FEATURES OF GI HORMONES: STRUCTURE AS A GUIDE TO BIOLOGICAL ACTION VI GI HORMONES IN PHYSIOLOGY 1. Secretin 7. Pancreatic Polypeptide 2 .. Gastrin 8. Vasoactive Intestinal Polypeptide 3. Cholecystokinin-Pancreozymin 9. Somatostatin 4. Gastric Inhibitory Polypeptide 1o. Substance P 5. Motilin 11. Bombesin 6. Glucagon, Enteroglucagon 12. Other Peptides VII GI HORMONES IN DISEASE A. GI Hormone-Secreting Tumors: Gastrinoma (Zollinger-Ellison Syndrome), and other causes of Hypergastrinemia; MEA Syndromes; VIP-oma (Watery­ Diarrhea, WDHH or Werner-Morrison Syndrome); Glucagonoma; Somatostatinoma; Pancreatic Polypeptide in Tumors; Substance P (Carcinoid). B. GI Hormones in Other Pathologic States. C. Diagnostic & Therapeutic Uses. VIII CONCLUSION 3 GLOSSARY ACTH - Corticotropin (adrenocorticotropic hormone) AMP - Adenosine monophosphate APUD - Amine precursor uptake and decarboxylation CCK, CCK- PZ - Cholecystokinin-pancreozymin EC - Enterochromaffin EG - Enteroglucagon GI - Gastrointestinal GIP - Gastric-inhibitory polypeptide LES - Lower esophageal sphincter MEA - Multiple endocrine adenomatosis MSH - Melanocyte-stimulating hormone (melanotropin) PP - Pancreatic polypeptide PZ - Pancreozymin RIA - Radioimmunoassay SP - Substance P STM - Standard test meal VIP - Vasoactive intestinal polypeptide WDHH (or WDHA) - Watery
    [Show full text]
  • Pancreas and Fat/Lipid Digestion
    Exocrine Pancreas Physiology Pancreatic Anatomy Pancreatic secretion Pancreatic enzymes Daniel S. Kamin MD Boston Children’s Hospital [email protected] Content Reviewers: Sohail Z. Husain, MD Veronique Morinville MD, FRCP(C) NASPGHAN Physiology Education Series Series Editors: Christine Waasdorp Hurtado, MD, MSCS, FAAP [email protected] Daniel Kamin, MD [email protected] Learning Objectives • Understand the normal development and anatomy of the pancreas • Understand the stimuli and cellular factors giving rise to pancreatic secretion • Know the mechanisms by which pancreatic enzymes are activated and remain functional • Be aware of age-related deficiency in exocrine pancreatic function Night blindness • A young man with morbid obesity undergoes roux-en-y gastric bypass. • 1 year later he notices that in the evening he falls down his stairs. • Vitamin A deficiency is diagnosed. Understanding the physiology of pancreatic and bile secretion, Used with permission intraluminal lipolysis, and micellar function explains why this happens! http://www.citelighter.com/science/surgery/knowledgecards/gastric-bypass Pancreas Physiology Overview • Bulk of bicarbonate secretion (more than what secreted in bile and from duodenum) • Enzymes for intra- luminal digestion • Secretin and CCK regulate • Maturational pancreatic insufficiency Used with permission Image from http://www.aboutcancer.com/pancreas1.htm Pancreatic Development • See Embryology and Anatomy of the Gastrointestinal Tract Pancreatic Microanatomy Pancreatic Acinar Secretory Products A • Proteases • Trypsinogen* • Chymotrypsinogen* A • Proelastase* • Procarboxypeptidase* • Procarboxypeptidase B* • Amylolytic enzyme • Amylase A • Lipases • Lipase • B Nonspecific esterase • Prophospholipase A2* • Nucleases • Deoxyribonuclease • Ribonuclease • Others • Pro-colipase* • Trypsin inhibitors A. Exocrine pancreas-- ascinar cells filled • Monitor peptid with secretory granules, cuboidal duct Stored and secreted in inactive form cells secrete bicarbonate-rich fluid B.
    [Show full text]
  • Secretin: Structure of the Precursor and Tissue Distribution of the Mrna (Intestine/Preprohormone/Cdna/Polymerase Chain Reaction) ALAN S
    Proc. Nati. Acad. Sci. USA Vol. 87, pp. 2299-2303, March 1990 Biochemistry Secretin: Structure of the precursor and tissue distribution of the mRNA (intestine/preprohormone/cDNA/polymerase chain reaction) ALAN S. KoPIN*, MICHAEL B. WHEELER, AND ANDREW B. LEITER Division of Gastroenterology, Department of Medicine, New England Medical Center, Boston, MA 02111 Communicated by Donald F. Steiner, January 5, 1990 (receivedfor review, November 17, 1989) ABSTRACT Secretin is a 27-amino acid gastrointestinal denum, while the levels reported for hypothalamus, thala- hormone that stimulates the secretion of bicarbonate-rich mus, and olfactory lobe were comparable to those in small pancreatic fluid. The unusually high number ofserine, leucine, intestine (9). Others report that brain contains either small and arginine residues in secretin has precluded the use of amounts (10, 11) or no secretin-like immunoreactivity (12). oligonucleotides to screen cDNA libraries to isolate a secretin In the present study, we have isolated cDNAs encoding the cDNA. In the present study, a short cDNA encoding porcine rat and porcine secretin precursors.t The deduced amino acid secretin was amplified from duodenal mucosal first-strand sequence includes a signal peptide, an N-terminal peptide, cDNA template by using 16,384- and 4096-fold degenerate secretin, and a 72-amino acid C-terminal peptide. We have primers in the DNA polymerase chain reaction. From the used the secretin cDNA as a probe in Northern blot hybrid- sequence of the amplified cDNA, an unambiguous oligonucle- izations to address unresolved questions regarding the tissue otide probe was designed to screen a cDNA library. Here we localization of secretin biosynthesis in the rat CNS and report the sequences of cDNAs encoding the porcine and rat gastrointestinal tract.
    [Show full text]
  • Secretin Cells in Coeliac Disease
    Gut: first published as 10.1136/gut.14.11.870 on 1 November 1973. Downloaded from Gut, 1973, 14, 870-874 Secretin cells in coeliac disease JULIA M. POLAK, A. G. E. PEARSE, SUSAN VAN NOORDEN, S. R. BLOOM, AND MARY A. ROSSITER From the Department of Histochemistry, Royal Postgraduate Medical School, London, the Department of Clinical Research, Middlesex Hospital, London, and the Department of Gastroenterology, Queen Elizabeth Hospital, London SUMMARY Immunofluorescence (anti-secretin), cytochemical, and ultrastructural studies were carried out on jejunal biopsies from 16 children with coeliac disease and from 17 controls with suspected malabsorption but normal jejunal morphology. In 11 of the 16 coeliacs there was generalized hyperplasia of endocrine cells and, specifically, of the secretin (S) cells. Further studies, on adult coeliacs as well as on children, combined with serum secretin assays, may establish whether the S cells are abnormally storing hormone because of inability to release it or because of excess production. Present observations suggest that abnormal secretion children with coeliac disease only minimal changes in of certain gut hormones may be involved in the serum insulin were observed during a glucose toler- malfunction of the intestine in coeliac disease. ance test (Grant, 1973). In this disorder the secretory response of the The evidence summarized above points to the http://gut.bmj.com/ exocrine pancreas to a standard meal is reduced conclusion that the pancreas itself is capable of (Worming, Mullertz, Thaysen, and Bang, 1967), as normal function in coeliac disease but that normal it also is after perfusion of the intestine with amino stimulation by secretin and/or CCK/PZ is not acids (which stimulate cholecystokinin secretion).
    [Show full text]